Identifying Extended‐Release Naltrexone Treatment for Opioid Use Disorder in <scp>US</scp> Medicaid Data
We found inconsistent patterns of XR-NTX codes across states indicating claim-based definitions should consider both drug and procedure codes to fully capture XR-NTX service delivery. Multiple definitions should be considered in sensitivity analyses given substantial variability in coding practices across states.
Authors
- Marissa J. Seamans (ORCID: https://orcid.org/0000-0002-5792-3848)
- Hillary Samples (ORCID: https://orcid.org/0000-0001-5773-3705)
- Anne M. Butler (ORCID: https://orcid.org/0000-0001-7307-6864)
- Rachael K. Ross (ORCID: https://orcid.org/0000-0002-2049-6918)
- Kara E. Rudolph (ORCID: https://orcid.org/0000-0002-9417-7960)
- Park Williams (ORCID: https://orcid.org/0000-0001-8176-8166)
Institutions
- Rutgers, The State University of New Jersey (US)
- University of California, Los Angeles (US)
- Washington University in St. Louis (US)
- New York Psychoanalytic Society and Institute (US)
- New York State Psychiatric Institute
- Fielding Graduate University (US)
- Columbia University (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1002/pds.70304
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00